Keros Therapeutics
KROS
KROS
112 hedge funds and large institutions have $617M invested in Keros Therapeutics in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 103 → 112 (+9)
2.03% less ownership
Funds ownership: 72.22% → 70.18% (-2%)
Holders
112
Holding in Top 10
3
Calls
$5.77M
Puts
$3K
Top Buyers
| 1 | +$12.9M | |
| 2 | +$9.92M | |
| 3 | +$5.51M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$5.49M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.22M |
Top Sellers
| 1 | -$18.5M | |
| 2 | -$4.21M | |
| 3 | -$4.14M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.49M |
| 5 |
Morgan Stanley
New York
|
-$2.19M |